Q2 2017

Source filing unavailable

Q2 2017 · —

Revenue

$25.45M

no prior Q2 2016 on file

Net Income

$902.00K

no prior Q2 2016 on file

EPS Diluted

$6.80

no prior Q2 2016 on file

Gross Profit$10,819,000—

Operating Income$1,832,000—

Operating Cash Flow$3,372,000

Same quarter

no prior Q2 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Trinity Biotech PLC · CIK 888721 · Engraved from SEC EDGAR